3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
4
Prostatic Neoplasms
3
Small Cell Lung Carcinoma
2
Sarcoma, Ewing
2
Rectal Neoplasms
2
Pulmonary Disease, Chronic Obstructive
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Head and Neck Neoplasms
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Tuberculosis
1
Thoracic Cancer
1
Shwachman-Diamond Syndrome
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Recurrence
1
Precancerous Conditions
1
Pneumonia
1
Pathologic Complete Response
1
Pancreatic Intraductal Neoplasms
1
Osteosarcoma
1
Osteoporosis
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Interventions
fludarabine phosphate
58
Cyclophosphamide
54
Peripheral Blood Stem Cell Transplantation
49
Mycophenolic Acid
39
Busulfan
38
Tacrolimus
37
Cyclosporine
33
Antilymphocyte Serum
33
Whole-Body Irradiation
32
Filgrastim
28
Methotrexate
27
Radiotherapy
20
Melphalan
18
Cytarabine
17
fludarabine
16
Etoposide
16
Methylprednisolone
14
ruxolitinib
11
sargramostim
9
Flow Cytometry
9
Cyclosporins
9
Cord Blood Stem Cell Transplantation
9
Alemtuzumab
9
thymoglobulin
8
Sirolimus
8
Psychiatric Rehabilitation
8
Granulocyte Colony-Stimulating Factor
8
Azacitidine
8
merphos
7
Decitabine
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Myeloproliferative Disorders
×
X-Rays
×
Clear all
NCT02580903
2020-09-16
MPNPH
Odense University Hospital
Completed
180 enrolled